Isolated focal cortical dysplasia type IIa

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:269001OMIM:607341Q04.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Isolated focal cortical dysplasia type IIa (FCD IIa) is a rare malformation of cortical development characterized by abnormal organization and structure of a localized area of the cerebral cortex. In FCD type IIa, the affected brain region contains dysmorphic (abnormally shaped and enlarged) neurons with disrupted cortical lamination, but without the presence of balloon cells (which distinguishes it from type IIb). This condition primarily affects the central nervous system and is one of the most common causes of drug-resistant focal epilepsy, particularly in children and young adults. The hallmark clinical feature of isolated FCD type IIa is recurrent seizures, which may begin at any age but frequently present during childhood. The seizure type depends on the location of the dysplastic cortex and can include focal motor seizures, focal seizures with impaired awareness, or secondary generalized tonic-clonic seizures. Some patients may also experience developmental delay, cognitive difficulties, or focal neurological deficits depending on the size and location of the lesion. The condition is typically identified through brain MRI, which may show cortical thickening, blurring of the gray-white matter junction, and signal abnormalities, although FCD IIa can sometimes be subtle or even undetectable on standard imaging. The primary treatment approach involves antiepileptic (antiseizure) medications, though a significant proportion of patients with FCD type IIa have pharmacoresistant epilepsy. For those who do not respond adequately to medication, surgical resection of the dysplastic cortex is the treatment of choice and can result in seizure freedom in a substantial number of cases. Accurate localization of the lesion through advanced neuroimaging, electroencephalography (EEG), and sometimes invasive monitoring is critical for surgical planning. The prognosis after surgery depends on the completeness of resection of the dysplastic tissue.

Also known as:

Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Variable

Can begin at different ages, from infancy through adulthood

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Isolated focal cortical dysplasia type IIa.

View clinical trials →

No actively recruiting trials found for Isolated focal cortical dysplasia type IIa at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Isolated focal cortical dysplasia type IIa community →

No specialists are currently listed for Isolated focal cortical dysplasia type IIa.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Isolated focal cortical dysplasia type IIa.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Isolated focal cortical dysplasia type IIaForum →

No community posts yet. Be the first to share your experience with Isolated focal cortical dysplasia type IIa.

Start the conversation →

Latest news about Isolated focal cortical dysplasia type IIa

No recent news articles for Isolated focal cortical dysplasia type IIa.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Isolated focal cortical dysplasia type IIa

What is Isolated focal cortical dysplasia type IIa?

Isolated focal cortical dysplasia type IIa (FCD IIa) is a rare malformation of cortical development characterized by abnormal organization and structure of a localized area of the cerebral cortex. In FCD type IIa, the affected brain region contains dysmorphic (abnormally shaped and enlarged) neurons with disrupted cortical lamination, but without the presence of balloon cells (which distinguishes it from type IIb). This condition primarily affects the central nervous system and is one of the most common causes of drug-resistant focal epilepsy, particularly in children and young adults. The ha

How is Isolated focal cortical dysplasia type IIa inherited?

Isolated focal cortical dysplasia type IIa follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.